C101H137F4N35S4 — CID 161034189
6-(4-tert-butylpiperazin-1-yl)-2-(3-methylbenzimidazol-5-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-(4-tert-butylpiperazin-1-yl)-2-(1-methylindazol-5-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-(4-cyclopropylpiperazin-1-yl)-2-(8-fluoro-2-methylquinolin-6-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-N-(5-methyl-1H-pyrazol-3-yl)-2-[2-(trifluoromethyl)quinolin-6-yl]sulfanylpyrimidin-4-amine;molecular hydrogen (PubChem CID 161034189) has the molecular formula C101H137F4N35S4 and a molecular weight of 2045.71 g/mol. Its IUPAC name is 6-(4-tert-butylpiperazin-1-yl)-2-(3-methylbenzimidazol-5-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-(4-tert-butylpiperazin-1-yl)-2-(1-methylindazol-5-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-(4-cyclopropylpiperazin-1-yl)-2-(8-fluoro-2-methylquinolin-6-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-N-(5-methyl-1H-pyrazol-3-yl)-2-[2-(trifluoromethyl)quinolin-6-yl]sulfanylpyrimidin-4-amine;molecular hydrogen.
| Compound Name | 6-(4-tert-butylpiperazin-1-yl)-2-(3-methylbenzimidazol-5-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-(4-tert-butylpiperazin-1-yl)-2-(1-methylindazol-5-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-(4-cyclopropylpiperazin-1-yl)-2-(8-fluoro-2-methylquinolin-6-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-N-(5-methyl-1H-pyrazol-3-yl)-2-[2-(trifluoromethyl)quinolin-6-yl]sulfanylpyrimidin-4-amine;molecular hydrogen |
|---|---|
| PubChem CID | 161034189 |
| Molecular Formula | C101H137F4N35S4 |
| Molecular Weight | 2045.71 g/mol |
| Exact Mass | 2044.06 |
| IUPAC Name | 6-(4-tert-butylpiperazin-1-yl)-2-(3-methylbenzimidazol-5-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-(4-tert-butylpiperazin-1-yl)-2-(1-methylindazol-5-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-(4-cyclopropylpiperazin-1-yl)-2-(8-fluoro-2-methylquinolin-6-yl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)pyrimidin-4-amine;6-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-N-(5-methyl-1H-pyrazol-3-yl)-2-[2-(trifluoromethyl)quinolin-6-yl]sulfanylpyrimidin-4-amine;molecular hydrogen |
| SMILES | Cc1cc(Nc2cc(N3CCN(C(C)(C)C)CC3)nc(Sc3ccc4c(cnn4C)c3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCN(C(C)(C)C)CC3)nc(Sc3ccc4ncn(C)c4c3)n2)n[nH]1.Cc1cc(Nc2cc(N3CCN(C4CCN(C)CC4)CC3)nc(Sc3ccc4nc(C(F)(F)F)ccc4c3)n2)n[nH]1.Cc1ccc2cc(Sc3nc(Nc4cc(C)[nH]n4)cc(N4CCN(C5CC5)CC4)n3)cc(F)c2n1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H] |
| InChI | InChI=1S/C28H32F3N9S.C25H27FN8S.2C24H31N9S.8H2/c1-18-15-25(37-36-18)33-24-17-26(40-13-11-39(12-14-40)20-7-9-38(2)10-8-20)35-27(34-24)41-21-4-5-22-19(16-21)3-6-23(32-22)28(29,30)31;1-15-3-4-17-12-19(13-20(26)24(17)27-15)35-25-29-21(28-22-11-16(2)31-32-22)14-23(30-25)34-9-7-33(8-10-34)18-5-6-18;1-16-12-21(30-29-16)26-20-14-22(32-8-10-33(11-9-32)24(2,3)4)28-23(27-20)34-18-6-7-19-17(13-18)15-25-31(19)5;1-16-12-21(30-29-16)26-20-14-22(32-8-10-33(11-9-32)24(2,3)4)28-23(27-20)34-17-6-7-18-19(13-17)31(5)15-25-18;;;;;;;;/h3-6,15-17,20H,7-14H2,1-2H3,(H2,33,34,35,36,37);3-4,11-14,18H,5-10H2,1-2H3,(H2,28,29,30,31,32);2*6-7,12-15H,8-11H2,1-5H3,(H2,26,27,28,29,30);8*1H |
| InChIKey | UAAOBLPJICOCDY-UHFFFAOYSA-N |
| XLogP | 20.26 |
| TPSA | 356.54 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 144 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2045.71 |
| LogP ≤ 5 | 20.26 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 35 |